GCBLX | RLBCX | GCBLX / RLBCX | |
Total Expense Ratio | 1.46 | 0.89 | 164% |
Annual Report Gross Expense Ratio | 1.46 | 0.89 | 164% |
Fund Existence | 33 years | 23 years | - |
Gain YTD | 6.106 | 9.802 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 384M | 255B | 0% |
Annual Yield % from dividends | 0.48 | 1.56 | 31% |
Returns for 1 year | -1.53 | 6.90 | -22% |
Returns for 3 years | 12.72 | 33.18 | 38% |
Returns for 5 years | 13.71 | 35.32 | 39% |
Returns for 10 years | 55.24 | 69.04 | 80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMEZ | 14.30 | 0.12 | +0.85% |
BlackRock Health Sciences Term Trust | |||
DRUP | 62.17 | 0.08 | +0.13% |
GraniteShares Nasdaq Sel Disruptors ETF | |||
SCCR | 25.67 | 0.02 | +0.08% |
Schwab® Core Bond ETF | |||
QMID | 27.93 | N/A | N/A |
WisdomTree U.S. Mid Cap Quality Gr | |||
UEVM | 55.03 | -0.08 | -0.14% |
VictoryShares Emerging Mkts Val MomtETF |